immunocal glutathione clinical study A Cystine-Rich Whey Supplement (Immunocal®) Delays Disease Onset and Prevents Spinal Cord Depletion in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis A Cystine-Rich Whey Supplement (Immunocal®)

Ingredients: Water, Ethylhexyl Methoxycinnamate, Butylene Glycol, Ethylhexyl Salicylate, Octocrylene, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Butyl Methoxydibenzoylmethane, Dipropylene Glycol, Niacinamide, Squalane, C14-22 Alcohols, 1,2-Hexanediol, Polyglyceryl-2 Stearate, Propanediol, Hydroxyacetophenone, Glyceryl Stearate, Stearyl Alcohol, C12-20 Alkyl Glucoside, Tromethamine, Centella Asiatica Extract, Carbomer, Melaleuca Alternifolia Extract, Hippophae Rhamnoides Fruit Extract, Vitis Vinifera Fruit Extract, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Uncaria Sinensis Extract, Glycerin, Adenosine, Disodium EDTA, Oryza Sativa Bran Extract, Hydrogenated Phosphatidylcholine, Caprylic/Capric Triglyceride, Sodium Hyaluronate, Glucose, Hydrolyzed Collagen, Sucrose Stearate, Glutathione, Cyclodextrin, Cetearyl Alcohol, Caprylyl Glycol, Beta-Glucan, Caprylhydroxamic Acid, Ethylhexylglycerin, Asiatic Acid, Asiaticoside, Madecassic Acid, Madecassoside, Tropolone, Hyaluronic Acid, Potassium Hyaluronate

Our results on metabolite differences between SPF and GF mice are comparable to other previous studies

D., Davies, J., Gandhi, R

About the REDEFINE clinical trial programme REDEFINE is a phase 3 clinical development programme with once-weekly subcutaneous CagriSema in obesity